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Myogenic-specific ablation of Fgfr1
impairs FGF2-mediated proliferation
of satellite cells at the myofiber niche
but does not abolish the capacity for
muscle regeneration
Zipora Yablonka-Reuveni*, Maria E. Danoviz, Michael Phelps and Pascal Stuelsatz*
Department of Biological Structure, University of Washington School of Medicine, Seattle, WA, USA
Skeletal muscle satellite cells (SCs) are Pax7+ myogenic stem cells that reside between
the basal lamina and the plasmalemma of the myofiber. In mature muscles, SCs are
typically quiescent, but can be activated in response to muscle injury. Depending on
the magnitude of tissue trauma, SCs may divide minimally to repair subtle damage
within individual myofibers or produce a larger progeny pool that forms new myofibers
in cases of overt muscle injury. SC transition through proliferation, differentiation and
renewal is governed by the molecular blueprint of the cells as well as by the extracellular
milieu at the SC niche. In particular, the role of the fibroblast growth factor (FGF)
family in regulating SCs during growth and aging is well recognized. Of the several
FGFs shown to affect SCs, FGF1, FGF2, and FGF6 proteins have been documented
in adult skeletal muscle. These prototypic paracrine FGFs transmit their mitogenic effect
through the FGFRs, which are transmembrane tyrosine kinase receptors. Using the
mouse model, we show here that of the four Fgfr genes, only Fgfr1 and Fgfr4 are
expressed at relatively high levels in quiescent SCs and their proliferating progeny.
To further investigate the role of FGFR1 in adult myogenesis, we have employed a
genetic (Cre/loxP) approach for myogenic-specific (MyoDCre-driven) ablation of Fgfr1.
Neither muscle histology nor muscle regeneration following cardiotoxin-induced injury
were overtly affected in Fgfr1-ablated mice. This suggests that FGFR1 is not obligatory
for SC performance in this acute muscle trauma model, where compensatory growth
factor/cytokine regulatory cascades may exist. However, the SC mitogenic response to
FGF2 is drastically repressed in isolated myofibers prepared from Fgfr1-ablated mice.
Collectively, our study indicates that FGFR1 is important for FGF-mediated proliferation
of SCs and its mitogenic role is not compensated by FGFR4 that is also highly expressed
in SCs.
Keywords: satellite cells, fibro/adipogenic progenitors, fibroblast growth factor, Pax7, MyoDCre, alpha7 integrin,
cardiotoxin injury, muscle spindles
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Introduction
Skeletal muscle is composed of multinucleated myoﬁbers that
are established during embryogenesis by fusion of myoblasts.
Addition of myoﬁber nuclei (myonuclei) or formation of new
myoﬁbers during postnatal and adult life depend on satellite cells
(SCs), Pax7+ myogenic progenitors that are localized between the
basal lamina and the plasmalemma of the myoﬁber (Mauro, 1961;
Seale et al., 2000; Yablonka-Reuveni, 2011). During postnatal
growth, at least some SCs are proliferative and contribute
progeny that fuse with the enlarging myoﬁbers (Moss and
Leblond, 1971; Schultz, 1996; Halevy et al., 2004; White et al.,
2010). In mature muscles, SCs are typically quiescent, but can
be activated in response to muscle injury (Schultz et al., 1978;
Montarras et al., 2013). Depending on the magnitude of tissue
trauma, SCsmay divideminimally to repair subtle damage within
individual myoﬁbers or produce a larger progeny pool that forms
new myoﬁbers in cases of overt muscle injury (Grounds and
Yablonka-Reuveni, 1993; Hawke and Garry, 2001). In addition
to generating myogenic progeny that fortify myoﬁbers, at least
some SCs can self-renew, thereby meeting the deﬁning criteria of
bona ﬁde resident stem cells (Collins et al., 2005; Day et al., 2007;
Kuang et al., 2007; Sacco et al., 2008).
At the molecular level, SCs and their progeny are tightly
regulated by highly orchestrated temporal expression of
transcription factors and cell cycle regulators, providing a
balance between SC quiescence, proliferation, diﬀerentiation
and renewal (Bentzinger et al., 2010; Yablonka-Reuveni and Day,
2011; Yin et al., 2013). To monitor progression through these
stages, researchers have relied on distinct marker signatures, in
particular, temporal expression of the paired box transcription
factor Pax7, and the myogenic regulatory factors MyoD and
myogenin (Yablonka-Reuveni and Rivera, 1994; Zammit
et al., 2006; Yablonka-Reuveni et al., 2008; Yablonka-Reuveni,
2011). Proliferating progeny maintain Pax7 expression as their
quiescent progenitors, but distinctly, are also MyoD-positive
(Zammit et al., 2004). A decline in Pax7, along with the
induction of myogenin, marks progeny that have entered into the
diﬀerentiation phase and subsequently may fuse into myotubes
(Shefer et al., 2006; Day et al., 2009). Re-emergence of cells that
express Pax7, but not MyoD, deﬁnes a self-renewing population
of SCs known as reserve cells (Halevy et al., 2004; Zammit et al.,
2004; Day et al., 2007).
Satellite cell transition through proliferation, diﬀerentiation
and renewal is not only governed by the molecular blueprint
of the cells, but is also regulated by the extracellular milieu
at the SC niche (Allen et al., 1984; Allen and Boxhorn, 1989;
Anderson, 2006; Brack and Rando, 2007; Shefer and Yablonka-
Reuveni, 2008; Yin et al., 2013; Wang et al., 2014). Isolated
myoﬁbers maintained in conditions where the SCs and their
progeny are retained at their native position, have oﬀered a
unique in vitro means to investigate the eﬀect of growth factors
on SC behavior at their native niche (Bischoﬀ, 1986a; Yablonka-
Reuveni and Rivera, 1994; Yablonka-Reuveni et al., 1999a). Using
this approach, hepatocyte growth factor (HGF) and selective
members of the ﬁbroblast growth factor (FGF) family have
been shown to enhance SC proliferation (Bischoﬀ, 1986a,b;
Yablonka-Reuveni et al., 1999a,b; Kastner et al., 2000; Wozniak
and Anderson, 2007), while transforming growth factor beta
(TGFβ1) has been found to repress proliferation (Bischoﬀ, 1990;
Yablonka-Reuveni and Rivera, 1997b). Our particular interest
in the role of the FGFs and their receptors in regulating SC
dynamics through life (Yablonka-Reuveni and Rivera, 1994,
1997b; Yablonka-Reuveni et al., 1999a,b; Kastner et al., 2000;
Shefer et al., 2006; Kwiatkowski et al., 2008) has prompted the
research described in the current study.
The FGFs are key players in the processes of proliferation
and diﬀerentiation of a wide range of cells and tissues. Over
20 FGFs, classiﬁed as paracrine (FGFs 1–10, 16–18, 20, 22),
endocrine (FGFs 15/19, 21, 23) and intracrine (FGFs 11–14)
types, have been discovered to date (Mason, 2007; Itoh and
Ornitz, 2011; Ohta and Itoh, 2014). Selective paracrine FGFs
have long been known to act as mitogens of SCs [i.e., FGF1,
FGF2, FGF4, and FGF6, but not FGF5, FGF7, and FGF8 (Sheehan
and Allen, 1999; Kastner et al., 2000)]. Importantly, several of
these paracrine FGFs that can promote SC proliferation (FGF1,
FGF2, FGF6) have been detected at the transcript and the protein
levels in adult skeletal muscle (Yamada et al., 1989; Alterio et al.,
1990; Le Moigne et al., 1990; Oliver et al., 1992; Clarke et al.,
1993; Dusterhoft et al., 1999; Kastner et al., 2000; Zhao and
Hoﬀman, 2004; Fon Tacer et al., 2010; Chakkalakal et al., 2012).
In particular, FGF2 (formerly known as basic FGF) has been used
extensively as the FGF of choice in many studies of SCs in single
myoﬁbers (Yablonka-Reuveni and Rivera, 1994, 1997b; Yablonka-
Reuveni et al., 1999a,b; Shefer et al., 2006) and as a routine
medium supplement in primary cultures (Rando and Blau, 1994;
Motohashi et al., 2014). Apart from its mitogenic eﬀect, FGF2
has been suggested to directly repress myoblast diﬀerentiation,
thereby supporting expansion of the proliferative pool (Clegg
et al., 1987; Olwin et al., 1994).
Studying SCs in isolated myoﬁbers under conditions that
retain SCs at the myoﬁber niche, we previously showed that SCs
from senile mice (29–33 months) could not enter a proliferative
state without FGF2 supplementation, whereas SCs from young
mice (3–6 months) did not require exogenous FGF2 (Shefer et al.,
2006). In accordance with our ﬁndings, a recent study reported
that FGF2 is required to remove age-associated proliferative
inhibition of SCs (Li et al., 2014). We also demonstrated
that an FGF2 activity-blocking antibody drastically reduced SC
activation/proliferation in isolated myoﬁbers from young rodents
(Yablonka-Reuveni and Rivera, 1994). Collectively, our studies
indicate that FGF2 is required for SC proliferation and that
FGF2 (or FGF2-mediated signaling) becomes rate limiting in
SC function in old age, and this may be an underlying factor
in the age-associated decline in SC numbers observed in some
limb muscles (Brack et al., 2005; Shefer et al., 2006, 2010, 2013).
However, it has been reported that excess FGF2 harbored in the
myoﬁbers of aging mice leads to SC depletion due to detrimental
proliferation (without self-renewal), rather than retention of the
quiescent state (Chakkalakal et al., 2012). Hence, means for direct
ablation of FGF2 signaling are needed to assist in determining its
role in SC performance during aging.
As the paracrine FGFs mediate their biological responses by
binding to cell surface FGF receptors (FGFR1, FGFR2, FGFR3,
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FGFR4), FGFR impairment oﬀers one possible approach for
studying the eﬀect of FGF2 signaling on SC performance.
The FGFRs share a common “generic” structure consisting of
an extracellular region containing three immunoglobulin-like
domains (Ig-1, Ig-2, Ig-3), a transmembrane domain, and an
intracellular domain containing a tyrosine kinase core. FGF
binding to the FGFR extracellular domain induces receptor
dimerization and activation of the tyrosine kinase domain, which
can initiate key downstream intracellular signaling pathways:
RAS–RAF–MAPK, PI3K–AKT, STAT, and PLCγ (Eswarakumar
et al., 2005; Mason, 2007; Lanner and Rossant, 2010; Goetz
and Mohammadi, 2013). While the FGFRs are encoded by
four separate genes (Fgfr1, Fgfr2, Fgfr3, Fgfr4), alternative
splicing variants, alongside the temporal and spatial regulation of
expressed FGF and FGFRs and the involvement of additional co-
factors, increase the complexity and speciﬁcity of FGF signaling
(Ornitz, 2000; Zhang et al., 2006; Mason, 2007; Itoh and Ornitz,
2011; Goetz and Mohammadi, 2013). Out of the four FGFRs,
typically only FGFR1 and FGFR4 have been considered in
the context of adult myogenesis, due to their relative higher
transcript levels observed in freshly isolated SCs and myogenic
cultures [(Sheehan and Allen, 1999; Cornelison et al., 2000;
Kastner et al., 2000; Jump et al., 2009; Chakkalakal et al.,
2012); current study]. Furthermore, to date only FGFR1 and
FGFR4 have been documented at the protein level in SCs or
their progeny (Cornelison et al., 2001; Kwiatkowski et al., 2008;
Cassano et al., 2011). While our overexpression studies have
suggested diﬀerent modes of function for FGFR1 and FGFR4
(Kwiatkowski et al., 2008), it is unknown whether these two
FGFRs can compensate for each other during SC myogenesis.
Pharmacological-based abrogation of FGFR-signaling has been
employed in order to elucidate the role of FGFR1 in the context
of SC dynamics (Chakkalakal et al., 2012; Bernet et al., 2014).
However, the inhibitory drug used, SU5402 (Mohammadi et al.,
1997), can theoretically target all FGFRs based on its eﬀect on
blocking FGFR tyrosine kinase function. Indeed, SU5402 has
been used as a general inhibitor of FGF signaling in diﬀerent
species regardless of the expressed FGFR (Udayakumar et al.,
2003; Delaune et al., 2005; Dvorak et al., 2005; Abe et al., 2007;
Thomsen et al., 2008; Vatsveen et al., 2009; Franzdottir et al.,
2010; Fukui and Henry, 2011; Li et al., 2013). Myogenic-speciﬁc
ablation or overexpression of Spry1, a member of the Sprouty
family of negative regulators of receptor tyrosine kinase signaling
(Cabrita and Christofori, 2008), were also employed to modulate
FGF signaling during adult myogenesis (Chakkalakal et al.,
2012). The Sprouty proteins, however, act as inhibitors of the
Ras/MAPK cascade, a pathway downstream of various receptor
tyrosine kinases beyond just the FGFRs (Mason, 2007; Cabrita
and Christofori, 2008), which can complicate data interpretation.
If FGFR signaling is essential for regulating SC pool size,
which in turn may be important for muscle homeostasis, then
a better understanding of this topic is needed when considering
future therapies for disease- or age-associated muscle wasting.
Gaining further understanding of the role of the FGFR system
in myogenesis requires models that facilitate direct FGFR
ablation, bypassing downstream interventions that may not
speciﬁcally target individual FGFRs and may aﬀect additional
tyrosine kinase receptor cascades. In the current study we have
aimed to gain insight into the role of FGFR1 during adult
myogenesis using Fgfr1-ablated mice. As standard Fgfr1-null
mice die during gastrulation (Deng et al., 1994; Yamaguchi
et al., 1994), investigations of the role of FGFR1 in fetal and
adult life have only become possible with the development of
conditional Fgfr1-null alleles (Xu et al., 2002; Trokovic et al.,
2003). Here, we have ablated Fgfr1 speciﬁcally in the myogenic
lineage using a genetic approach with a Cre/loxP mouse model
that relies on the MyoDCre allele to mediate excision of the
ﬂoxed Fgfr1 gene. MyoD is well recognized as a master regulator
of the myogenic lineage speciﬁcation during embryogenesis
(Weintraub et al., 1991). While SCs are thought to express MyoD
only upon their activation (Yablonka-Reuveni and Rivera, 1994;
Cornelison and Wold, 1997; Yablonka-Reuveni et al., 2008), SC
progenitors do emerge during embryogenesis from a MyoD-
expressing lineage (Kanisicak et al., 2009; Yamamoto et al., 2009).
Thereby, MyoDCre-mediated excision of ﬂoxed genes would
occur in the embryonic muscle and be stably maintained in
the myogenic lineage through adult life. Here we show that
myogenic-speciﬁc ablation of Fgfr1 does not appear to inﬂuence
muscle morphology or regeneration following cardiotoxin-
induced damage in adult mice. Nevertheless, our study provides
novel evidence for the obligatory role for FGFR1 in mediating
FGF2mitogenic eﬀect on SCs that is not compensated by FGFR4,
which is also highly expressed in SCs.
Materials and Methods
Mice
Experimental procedures were approved by the University of
Washington Institutional Animal Care and Use Committee.
Mice were typically 4–6 months of age. Knockin heterozygous
males MyoDCre [MyoD1tm2.1(icre)Glh (Kanisicak et al., 2009)]
provided by David Goldhamer, backcrossed by us to C57BL/6,
were bred with knockin reporter females R26mTmG [Gt(ROSA)
26Sortm4(ACTB−tdTomato,−EGFP)Luo/J (Muzumdar et al., 2007)] to
generate adult F1 MyoDCre/+/R26mTmG/+ double heterozygous
animals. Mice harboring ﬂoxed Fgfr1 alleles (Trokovic et al.,
2003) were provided by David Ornitz (White et al., 2007).
These mice additionally harbored ﬂoxed FGFR2 (Yu et al.,
2003). Nevertheless, as discussed in the Introduction, FGFR2
has been considered not relevant in adult myogenesis and
indeed, as shown in Results, Fgfr2 transcript expression in
SCs and their progeny is negligible. The Fgfr1ﬂ/ﬂ/Fgfr2ﬂ/ﬂ
females were crossed with MyoDCre/+/R26mTmG/+ males and
the resulting MyoDCre/+/R26mTmG/+/Fgfr1ﬂ/+/Fgfr2ﬂ/+ males
were backcrossed with Fgfr1ﬂ/ﬂ/Fgfr2ﬂ/ﬂ females to produce
MyoDCre/+/R26mTmG/+/Fgfr1ﬂ/ﬂ/Fgfr2ﬂ/ﬂ experimental
animals harboring muscle-speciﬁc (i.e., MyoD-driven) Fgfr
deletions. The FGFR1ﬂ allele contains loxP sites ﬂanking exons
8–15 that encompass the transmembrane domain and most of
the intracellular region (Trokovic et al., 2003). The FGFR2ﬂ allele
contains loxP sites ﬂanking exons 8-10 that encode a portion of
the ligand binding Ig-3 domain and the transmembrane domain
(Yu et al., 2003).
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Primers for genotyping the MyoDCre (JAX mice stock
#014141) and R26mTmG (JAX mice stock #007676) alleles were
according to Jackson Lab. Primers for genotyping the ﬂoxed Fgfr
alleles were according to (Trokovic et al., 2003; White et al.,
2007). Myogenic speciﬁcity of the MyoDCre-driven Fgfr deletions
was conﬁrmed by the detection of Fgfr delta alleles (Fgfr1 ,
Fgfr2) only in skeletal muscles but not in other control organs;
PCR primers were according to (Trokovic et al., 2003; White
et al., 2007). Likewise, GFP ﬂuorescence was detected only in
skeletal muscle myoﬁbers and SCs as we previously published for
MyoDCre/+/R26mTmG/+ mice (Stuelsatz et al., 2012, 2014).
Mice carrying a MyoD-null allele (Rudnicki et al., 1992) or
α7integrin-null allele (Flintoﬀ-Dye et al., 2005) in a heterozygous
or homozygous format were additionally used for comparison
when analyzing SC numbers in isolated myoﬁbers from
Fgfr1/Fgfr2-ablated mice. Both null strains were utilized in our
earlier studies (Yablonka-Reuveni et al., 1999a; Kirillova et al.,
2007; Rooney et al., 2009; Stuelsatz et al., 2012) and genotyped
according to published procedures (Valdez et al., 2000; Flintoﬀ-
Dye et al., 2005). Apart from the MyoD+/− and MyoD−/− mice
that were on Balb/C background, all other strains used in this
study were on enriched C57BL/6 background.
Cell Sorting by Flow Cytometry
Cells were isolated from hindlimb [limb; pooled tibialis anterior
(TA), extensor digitorum longus (EDL) and gastrocnemius] or
diaphragm muscles of ﬂoxed FGFR and control mice harboring
the MyoDCre and the R26mTmG alleles. The R26mTmG reporter
operates on a membrane-localized dual ﬂuorescent system
where all cells express Tomato until Cre-mediated excision of
the Tomato gene allows for GFP expression in the targeted
cell lineage (Muzumdar et al., 2007). Consequently, when the
R26mTmG allele is combined with MyoDCre allele all skeletal
muscles and their resident SCs are GFP+ (Stuelsatz et al.,
2014) due to ancestral MyoD expression in the myogenic
lineage (Kanisicak et al., 2009). Using this muscle-speciﬁc
reporter model, the isolated cells are sorted into myogenic
and non-myogenic populations according to GFP vs. Tomato
ﬂuorochrome, respectively, combined with antigen-based sorting
for maximal puriﬁcation as we previously described (Stuelsatz
et al., 2014). In brief, cell suspensions were released from
harvested muscles by collagenase/dispase digestion and were
ﬁrst incubated with 10 μM Hoechst 33342 (Sigma-Aldrich) for
30 min at 37◦C to label cell nuclei, followed by incubation
with the following ﬂuorescently conjugated antibodies (from
eBioscience): anti-Sca1 (APC, clone D7), anti-CD31 (PECy7,
clone 390), anti-CD45 (PECy7, clone 30-F11). Cell sorting was
then performed using an Inﬂux Cell Sorter (BD Biosciences)
equipped with 350, 488, and 638 nm lasers. All sorted cells
were collected within the G0-G1 population depleted of CD31+
(endothelial) and CD45+ (hematopoietic) cells, with myogenic
and non-myogenic populations isolated as GFP+/Sca1− and
Tomato+/Sca1+ cells, respectively. Gates were determined by
comparing ﬂuorophore signal intensities between the unstained
control and each single antibody/ﬂuorophore control. Data
was acquired at 20,000–100,000 events per sample and sorted
cells were collected in our culture media described below.
Subsequent analysis and ﬂow cytometry plots were generated
using FlowJo (TreeStar). Sorted populations were either used as
freshly isolated cells for gene expression studies or ﬁrst expanded
in primary cultures before harvested for DNA/RNA isolation and
subsequent PCR/RT-PCR analyses as detailed next.
Primary Cultures of Sorted Myogenic and
Non-myogenic Populations
Cells were cultured according to our routine procedures
for mouse primary cultures (Danoviz and Yablonka-Reuveni,
2012; Stuelsatz et al., 2014). The basal solution used for all
culture medium preparations consisted of Dulbecco’s modiﬁed
Eagle’s medium (DMEM, high glucose, with L-glutamine,
110 mg/l sodium pyruvate, and pyridoxine hydrochloride,
Hyclone) supplemented with antibiotics (50 U/ml penicillin and
50 mg/ml streptomycin, Gibco-Life Technologies). Sorted cells
were cultured in 12-well culture plates pre-coated with Matrigel
(BD Biosciences, diluted to a ﬁnal concentration 1 mg/ml) using
our standard DMEM-based medium containing 20% fetal bovine
serum (Gibco-Life Technologies), 10% horse serum (Gibco-Life
Technologies), and 1% chicken embryo extract [prepared from
whole 10-day-old embryos as detailed in Notes #4 and 5 in
(Danoviz and Yablonka-Reuveni, 2012)] and were incubated at
37◦C, 5% CO2. Cultures were initiated at a density of 1–2 × 104
cells per well. After the initial plating, growth medium was
replaced every 3 days.
Quantitative Gene Expression Analysis of
Freshly Sorted Cells
RNA was isolated from freshly sorted myogenic and non-
myogenic populations and reverse transcribed according to our
published procedure (Day et al., 2010). Sorted cell populations
were pelleted (400 × g for 10 min followed by 90 s at 12,000 × g)
and suspended in the lysis buﬀer from the RNeasy Plus Micro
kit (Qiagen) used to isolate total RNA. The RNA was then
quantiﬁed using an Agilent Bioanalyzer and reverse transcribed
(at 0.4 ng/μl) into cDNA using the iScript reverse transcriptase
(Bio Rad). Gene expression was determined by SYBR Green-
based quantitative PCR using 1 μl cDNA per reaction (20 μl
ﬁnal volume) on an ABI 7300 Real Time PCR machine (Life
Technologies) as we previously described (Phelps et al., 2013)
except that the annealing temperature for Fgfr1 and Fgfr2 primer
sets was adjusted at 66◦C instead of the standard 63◦C used for
the remaining primer sets. Raw qPCR cycle threshold values for
each individual sample were normalized to eukaryotic translation
elongation factor 2 (Eef2) reference gene expression as in (Phelps
et al., 2013). Each sample was analyzed in triplicate. Genes were
considered expressed if cycle threshold values (raw Ct) of less
than 33 cycles were detected.
Primer sequences were (fwd/rev): Pax7, GCCACAGCTTC
TCCAGCTAC/CACTCGGGTTGCTAAGGATG (120 bp, UCSC
Genome Browser ID Pax7_uc008vms.1_1_1_2); Fgfr1, GCCC
TGGAAGAGAGACCAGC/GAACCCCAGAGTTCATGGATGC
[244 bp, (Kwiatkowski et al., 2008)]; Fgfr2, GCCTCTCGAA
CAGTATTCTCCT/ACAGGGTTCATAAGGCATGGG [103 bp,
PrimerBank ID 2769639a1, (Spandidos et al., 2010)]; Fgfr3,
GGCTCCTTATTGGACTCGC/TCGGAGGGTACCACACTTTC
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[219 bp, (Deng et al., 1996)]; Fgfr4, TTGGCCCTGTTGAGCAT
CTTT/GCCCTCTTTGTACCAGTGACG (189 bp, PrimerBank
ID 6679789a1); Eef2, TGTCAGTCATCGCCCATGTG/CATCCT
TGCGAGTGTCAGTGA (123 bp, PrimerBank ID 33859482a1).
The ﬁnal concentration of all primers was 500 nM.
Genomic and Transcriptional Analysis of
Cultured Cells
Sorted cells cultured for 7 days were rinsed twice with DMEM
before adding the lysis buﬀer from the AllPrep DNA/RNA Mini
kit (Qiagen) used for simultaneous puriﬁcation of genomic DNA
and total RNA. Resulting preparations were quantiﬁed with a
NanoDrop spectrophotometer. Genomic analyses were done by
using 5 μl of DNA solution (adjusted to 10 ng/μl) per PCR
reaction (25 μl ﬁnal volume). PCR primers used for Fgfr1 and
Fgfr2 genomic products (wildtype, ﬂox and ) were according
to (White et al., 2007). Transcript expression analysis was done
by semi-quantitative RT-PCR according to our standard protocol
(Day et al., 2007). Brieﬂy, the RNA was reverse transcribed (at
20 ng/μl) into cDNA using the iScript reverse transcriptase (Bio
Rad) and 5 μl of cDNA per PCR reaction (25 μl ﬁnal volume)
were used. PCR primers used for transcript expression analysis
were previously described by us in (Kwiatkowski et al., 2008;
Stuelsatz et al., 2012) and were used here at a ﬁnal concentration
of 400 nM. Expression of Tbp (TATA box binding protein)
housekeeping control gene served as quality and loading control
as in (Stuelsatz et al., 2012). For all PCR reactions, the following
cycling parameters: 95◦C for 15 min, 22–30 cycles of 94◦C for
40 s, 60◦C for 50 s, 72◦ for 1 min, with a ﬁnal extension step
of 72◦C for 10 min were used. PCR products were separated on
1.5% agarose gels containing 1:10,000 dilution of SYBR Green I
(Molecular Probes). Gels were imaged using Gel Logic 212 Pro
(Carestream).
Quantification of SCs on Isolated Myofibers
Single myoﬁbers were isolated from the EDL muscle as we
previously described (Day et al., 2010; Keire et al., 2013). For
each mouse strain and for each condition tested, myoﬁbers were
typically isolated from 3 mice. For analyzing the number of SCs
on freshly isolated myoﬁbers, we relied on Pax7 immunostaining
following our standard approach using adherent myoﬁbers
where each myoﬁber is dispensed into an individual Matrigel-
coated well (Shefer et al., 2006; Day et al., 2007; Keire et al.,
2013) prior to ﬁxation and immunostaining. For analyzing
SC proliferation/diﬀerentiation, myoﬁbers were cultured for
3 days in non-coated wells (24-well trays, 1 myoﬁber per
well) using a DMEM-based medium containing 10% horse
serum, an approach that yields non-adhering myoﬁbers and
maintains the SCs and their progeny associated with the parent
myoﬁbers [adapted from (Zammit et al., 2004)]. For myoﬁbers
treated with FGF, FGF2 was supplemented at 5 ng/ml (R&D
Systems, recombinant human FGF basic, #234-FSE-025). The
cultures were initiated in 0.3 ml and the replenishment of
the medium (±FGF2) was achieved by adding fresh medium
(0.2 ml) on culture day 1 and performing partial medium
change (0.25 ml) on culture day 2; this approach ensured
that myoﬁbers were not disturbed during medium change.
Myoﬁbers were ﬁxed on day 3 by adding to the medium
an equal volume of 4% paraformaldehyde [PFA, prepared
as detailed in Note# 14 in (Keire et al., 2013)]. SCs were
analyzed by immunostaining using mouse antibodies against
Pax7 [Developmental Studies Hybridoma Bank (DSHB), ascites,
1:1000], MyoD (BD Biosciences, 1:800), Myogenin (DSHB,
supernatant, 1:5) and counterstaining with DAPI according to
our standard protocol for blocking, rinsing and mounting the
myoﬁbers (Shefer et al., 2006; Keire et al., 2013), except that
extra care had to be taken due to the non-adherent nature of the
myoﬁbers.
Muscle Injury and Histology
Mice were anesthetized with isoﬂurane. For each mouse, the
TA muscle from one leg was injected with 25 μl of 20 μM
cardiotoxin (Sigma C9759), while the TA from the contralateral
leg was injected with 25 μl of 0.9% NaCl as a control. TAs
(with EDLs attached, referred later as TA/EDL) were harvested
at diﬀerent time points after injury, embedded in OCT (Tissue-
Tek) and ﬂash frozen in isopentane cooled with liquid nitrogen.
Transverse sections (10 μm) prepared using a Leica CM1850
cryostat were stained with hematoxylin and eosin [H&E, as
described in (Stuelsatz et al., 2015)] or alternatively ﬁxed with 2%
PFA for 10 min before being stained with DAPI when analyzed
for GFP and Tomato ﬂuorochrome expression.
FGFR4 Immunodetection
FGFR4 immunolabeling was performed on unﬁxed cryosections
or on ﬁxed primary myogenic cultures processed according to
our standard protocol (Kwiatkowski et al., 2008; Stuelsatz et al.,
2014). Cultures were prepared from Pronase digested muscle
and grown on gelatin as in (Danoviz and Yablonka-Reuveni,
2012) before being ﬁxed with ice-cold methanol as we previously
published (Yablonka-Reuveni and Rivera, 1997a). In all cases,
specimens were prepared from limb muscle of wildtype mice.
Rabbit anti-FGFR4 was either from Santa Cruz Biotechnology or
produced in our laboratory [(Kwiatkowski et al., 2008), available
from Millipore]. FGFR4 immunolabeling of cryosections was
done in combination with laminin immunodetection (Stuelsatz
et al., 2014) to identify presumptive SCs based on their location
underneath the myoﬁber basal lamina.
Microscopy and Imaging
Cell culture and histological observations were made with an
inverted ﬂuorescent microscope (Eclipse TE2000-S, Nikon).
Images were acquired using CoolSNAP ES monochrome CCD
camera (Photometrics) controlled withMetaVue Imaging System
(Universal Imaging Corporation). For acquiring real color images
of H&E stained muscle sections, images were taken with a
Digital Sight DS-Ri1 color camera controlled by NIS-Elements F
software (Nikon). Digitized images were assembled using Adobe
Photoshop software. For ﬁnal images of tissue cross sections
showing the whole TA/EDL muscle, several pictures were taken
(with a 10 or 20x objective) and merged together, resulting in a
high-resolution view of the entire muscle cross-sectional area.
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Statistics
Data were analyzed by one-way ANOVA (p < 0.05) with
Bonferroni–Holm post hoc analysis using Excel with Daniel’s XL
Toolbox Add-In (by Daniel Kraus, Würzburg, Germany).
Results and Discussion
Experimental Approach
To achieve muscle-speciﬁc ablation of FGFR1 we have used
a Cre/loxP genetic approach relying on the MyoDCre allele
to mediate ablation of the ﬂoxed Fgfr1 gene. Regardless of
muscle origin, virtually all SCs in adult muscles are derived
from progenitors that have expressed the MyoDCre allele during
embryogenesis (Kanisicak et al., 2009; Yamamoto et al., 2009).
Hence, as detailed in the Introduction, MyoDCre-mediated
excision of ﬂoxed genes would occur in the embryonic muscle
and be stably maintained in the myogenic lineage through
adult life. Indeed, our use of the R26mTmG mouse (a ﬂoxed
dual ﬂuorescent reporter system described in Materials and
Methods), crossed with the MyoDCre mouse, has clearly
demonstrated speciﬁcity of the MyoDCre-mediated excision
(i.e., GFP expression) in all adult muscles in both myoﬁbers
(which are formed during embryogenesis by myoblasts fusion)
and SCs (Stuelsatz et al., 2012, 2014, 2015). Moreover,
this speciﬁc expression of GFP in the myogenic lineage of
MyoDCre × R26mTmG mice has provided us with an eﬀective
tool for sorting SCs (GFP+) from non-myogenic (Tomato+)
populations (Stuelsatz et al., 2012, 2014, 2015). While we were
mostly interested in the present study in the role of FGFR1,
the founder mice we had received to establish our colony
harbored both ﬂoxed Fgfr1 and Fgfr2 alleles. As detailed in
the Introduction, Fgfr2 has been considered not relevant in
adult myogenesis and indeed, as shown in Figures 1 and 2,
its expression level in SCs and their progeny is negligible.
However, Fgfr2 could have theoretically been upregulated in
the cell culture conditions used in the current study and/or
upon Fgfr1 ablation. Hence, in this original investigation of
the eﬀect of Fgfr genetic ablation on the myogenic lineage
we decided to retain both Fgfr1 and Fgfr2 ﬂoxed alleles.
Mice carrying these myogenic-speciﬁc (MyoDCre-driven) double
homozygous deletions are referred to throughout the manuscript
as mR1//R2/, while control mice, wildtype for Fgfr1 and
Fgfr2, or harboring ﬂoxed Fgfr1 and Fgfr2 alleles, are referred
to as R1+/+/R2+/+ or R1ﬂ/ﬂ/R2ﬂ/ﬂ, respectively. The mR1 //
R2/ mice (with or without the R26mTmG allele) were fertile
and appeared normal by size and overall morphology (mice were
followed up to 16 months of age).
Fgfr Expression in Freshly Isolated SCs
Before embarking on Fgfr ablation, we wished to analyze
endogenous Fgfr transcript levels in freshly isolated SCs in
comparison with non-myogenic cells. Gene expression analyses
were performed on freshly isolated populations sorted from
limb and diaphragm muscles of MyoDCre/+/R26mTmG/+ mice
(Figure 1, quantitative RT-PCR). For both muscle types analyzed,
the Pax7 data validates the myogenic nature of the GFP+
FIGURE 1 | Fgfr expression in freshly isolated SCs from limb and
diaphragm muscles of MyoDCre/+/R26mTmG/+ mice. Myogenic and
non-myogenic cell populations were sorted by flow cytometry (based on GFP
and Tomato fluorescence, respectively, and cell surface antigens) and
analyzed by quantitative RT-PCR. Gene expression values were normalized to
Eef2 reference gene expression (Ct). Average Ct values for Eef2 gene (±SD)
were 23.49 ± 0.09 (limb myogenic), 22.90 ± 0.04 (diaphragm myogenic),
20.84 ± 0.01 (limb non-myogenic), and 20.42 ± 0.01 (diaphragm
non-myogenic).
population; i.e., Pax7, the classic marker of SCs, was expressed
only by the sorted GFP+ population but not by the Tomato+
non-myogenic population (Figure 1). As additionally shown in
Figure 1, Fgfr1 was expressed at a relatively high level by both
the myogenic and non-myogenic populations, while Fgfr4 was
expressed only by the myogenic population, in accordance with
our previous rat studies (Kastner et al., 2000). Fgfr2 was below
detection level in the myogenic population, while some Fgfr2
expression was demonstrated by the non-myogenic population.
Fgfr3 was detected at relatively low level in both the myogenic
and non-myogenic populations (Figure 1).
MyoDCre Induces Effective Deletions of the
Floxed Fgfr1 and Fgfr2 Alleles in the
Myogenic Lineage without Modulating
Endogenous Levels of Fgfr3 and Fgfr4
The eﬃciency of MyoDCre-driven Fgfr1/Fgfr2 deletions in SCs
was evaluated concurrently at the genomic (PCR) and transcript
(RT-PCR) levels for both limb and diaphragmmuscles (Figure 2).
The cells were isolated from mR1//R2/ and control
R1+/+/R2+/+ mice that also harbored the R26mTmG reporter
to facilitate cell sorting of SCs vs. non-myogenic cells and to
conﬁrm the purity of the sorted populations in culture according
to GFP vs. Tomato reporter color, respectively (Figure 2A). To
ensure suﬃcient material for the analyses, and also to obtain
insight into possible modulations in Fgfr gene expression upon
proliferation/diﬀerentiation vs. freshly isolated cells (Figure 1),
the sorted cells were cultured for 7 days in our standard rich–
medium conditions, then harvested for simultaneous isolation of
DNA and RNA preparations.
Notably, there were no apparent diﬀerences in overall
morphology of the myogenic cultures from Fgfr1/Fgfr2-ablated
(mR1//R2/) and control (R1+/+/R2+/+) mice, whether
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FIGURE 2 | MyoD-driven Cre induces effective deletions of Fgfr1 and
Fgfr2 in the myogenic lineage without modulating gene expression
levels of Fgfr3 and Fgfr4. Myogenic (GFP+ ) and non-myogenic (Tomato+ )
cell populations were sorted by flow cytometry (as in Figure 1) from limb
and diaphragm muscles (denoted as L and D, respectively) of
MyoDCre/+/R26mTmG/+/Fgfr1fl/fl/Fgfr2fl/fl (mR1//R2/) and control
MyoDCre/+/R26mTmG/+ (R1+/+/R2+/+ ) mice. (A) Representative images of
sorted GFP+ and Tomato+ cell populations isolated from hindlimb muscles
and cultured for 7 days before being processed for simultaneous DNA and
RNA isolation and further PCR and RT-PCR analyses, respectively. As shown
here, the myogenic (GFP+ ) cultures displayed the initiation of myotube
formation that became more prominent by culture days 10–14 (not shown),
while the non-myogenic (Tomato+ ) cultures were void of myotubes. (B) PCR
analysis of the presence of the different Fgfr1 and Fgfr2 alleles (wt, flox, or 
alleles) at the genomic level. The detection of PCR products of the
Cre-mediated genomic deletions () solely in myogenic (GFP+ ) cells confirms
the muscle-specific deletion of Fgfr1 and Fgfr2 genes. (C) Semi-quantitative
RT-PCR analysis of Fgfr transcript levels. Fgfr1 and Fgfr2 transcripts were
absent in myogenic (GFP+ ) cells from mR1//R2/ mice (in agreement
with the genomic analysis), while expressed at a relatively high (Fgfr1) and
low (Fgfr2) levels, in control myogenic (GFP+ ) cells from R1+/+/R2+/+ mice.
In contrast, Fgfr3, Fgfr4, and c-Met were each detected at a similar level in
the myogenic cultures from mR1//R2/ vs. R1+/+/R2+/+ mouse
strains. The observed higher Fgfr4 expression levels in diaphragm (vs. limb)
myogenic cultures from both mR1//R2/ and R1+/+/R2+/+ mice
appear to coincide with the higher myogenin expression levels observed.
cells were isolated from limb (Figure 2A) or diaphragm
muscles (data not shown). For both mouse strains, the cultured
GFP+ cells demonstrated typical myogenic features, fusing into
myotubes by day 7 (Figure 2A), with myotubes enlarging
in number and size in subsequent days (not shown). The
non-myogenic cultures (Tomato+) from both Fgfr-deleted and
control mice harbored typical features of ﬁbroblastic cells as
expected, with no myotubes detected even when following the
cultures for longer time.
The genomic analysis of the diﬀerent Fgfr1 and Fgfr2 alleles
(wt, ﬂox, or  alleles) validated that the mice harbored the
anticipated alleles in accordance with mouse genotype and cell
type analyzed (Figure 2B). The detection of genomic PCR
products speciﬁc of the MyoDCre-mediated Fgfr1 and Fgfr2
genomic deletions ( allele) solely in myogenic cells conﬁrmed
muscle-speciﬁc deletions while the concurrent absence of any
residual ﬂox allele revealed the high eﬃciency of the Cre-
mediated recombination in the SC lineage.
Fgfr transcript evaluation by semi-quantitative RT-PCR in
cultures from both limb (L) and diaphragm (D) further
demonstrates the eﬀectiveness of MyoDCre-driven Fgfr1-ablation
in the myogenic lineage (Figure 2C) while Fgfr2 is already barely
detected in the myogenic lineage from the non-ablated control.
One primer of each pair used to detect Fgfr1 or Fgfr2 transcripts
is localized within the targeted ﬂoxed region, thereby avoiding
detection of truncated mRNAs that may be produced by the 
alleles. Nevertheless,mutant FGFR proteins potentially translated
from such truncated mRNA would be non-functional due to the
lack of critical domains (see Materials and Methods). Indeed,
as anticipated based on their location within the corresponding
Fgfr ﬂoxed region, our Fgfr1/Fgfr2 primers did not produce
any RT-PCR products when analyzing Fgfr1/Fgfr2 mRNA
expression in the myogenic lineage from mR1//R2/ mice
(Figure 2C). This is in contrast to that seen in non-myogenic
cell cultures where both Fgfr1 and Fgfr2 are expressed at a
relatively high level for both mouse strains analyzed (Figure 2C),
demonstrating the speciﬁcity of the Fgfr1/Fgfr2 ablation to the
myogenic lineage. Fgfr3 and Fgfr4 expression levels in myogenic
cells were unaﬀected when comparing myogenic cells from
mR1//R2/ vs. R1+/+/R2+/+ muscles. Likewise, the level
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of c-Met, the receptor for HGF, also an established mitogen of
SCs as detailed in the Introduction, was unaﬀected following
Fgfr1/Fgfr2 deletion (Figure 2C). Hence, there is no apparent
compensatory upregulation of Fgfr3, Fgfr4, or c-met in the
Fgfr1/Fgfr2-ablated myogenic lineage.
The data in Figure 2C illustrate additional noteworthy points
regarding Fgfr expression in cultures from both limb (L) and
diaphragm (D) in the context of the control R1+/+/R2+/+
cultures. (i) Fgfr3 appears to be expressed at a higher expression
level in the myogenic cultures vs. the non-myogenic cultures
and Fgfr4 is clearly expressed only in the myogenic cultures.
(ii) When compared to Fgfr expression levels in freshly isolated
populations from R1+/+/R2+/+ control mice (Figure 1), Fgfr1
and Fgfr4 appear to retain the same expression proﬁle in the day 7
cultures (with no Fgfr4 being detected in the non-myogenic cells),
but Fgfr2 and Fgfr3 appear to be up-regulated in the cultured
non-myogenic and myogenic cells, respectively. Our additional
unpublished studies of limb-derived sorted populations have
shown that Fgfr2 expression level continues to rise in the non-
myogenic population with time in culture, concomitant with
adipogenic diﬀerentiation that takes place uniquely in this Sca1+
sorted population. The latter non-myogenic population has
previously been deﬁned by others and us as ﬁbro/adipogenic
progenitors (Joe et al., 2010; Stuelsatz et al., 2014).
Muscle Tissue of Adult mR1//R2/ Mice
Does Not Show Apparent Signs of
Histopathology or Abolishment of
Regenerative Activity
Histological examination of muscle tissues from Fgfr1/Fgfr2-
ablated mice showed no apparent diﬀerences compared to the
control (R1ﬂ/ﬂ/R2ﬂ/ﬂ) mice. Low and high magniﬁcation images
of H&E stained cross sections processed from TA/EDL of
mR1//R2/ and control R1ﬂ/ﬂ/R2ﬂ/ﬂ mice demonstrate for
both mouse strains a normal muscle morphology (Figure 3).
Next, we analyzed muscle regeneration in mR1//R2/
mice (Figures 4 and 5) following intramuscular administration
of cardiotoxin, which speciﬁcally destroys the myoﬁbers but
preserves SCs (Harris, 2003). As seen in Figure 4, while most of
the cardiotoxin-injected muscle tissue did not initiate myoﬁber
formation on day 7 post-injury and still demonstrated large areas
of inﬂammatory cell inﬁltrations at day 14, by day 21 there
was an eﬀective regenerative process throughout the muscle as
observed by the characteristic presence of central myonuclei
(Figure 4). Our unpublished studies with wildtype adult mice
have demonstrated formation of nascent regenerative myoﬁbers
by day 7 following cardiotoxin injury and an almost complete
myoﬁber recovery by day 14 post-injury. Hence, it appears that
mR1//R2/ injured muscle has a lag inmuscle regeneration.
Nevertheless, our data (Figures 4 and 5) clearly indicate a
thorough regeneration of the injured muscle by day 21 regardless
of Fgfr1/Fgfr2 ablation in the myogenic lineage.
This injury study presented in Figures 4 and 5 was done
in mR1//R2/ mice that also harbored the R26mTmG allele
to facilitate direct tracking of myogenic cells/myoﬁbers (GFP+)
vs. non-myogenic cells (Tomato+), and as expected the newly
FIGURE 3 | Muscle tissue of adult mR1//R2/ mice does not
appear different from that of control muscle from R1+/+/R2+/+ mice.
Representative images of H&E stained cross sections of TA/EDL from
10-month-old (A) mR1//R2/ and (B) R1+/+/R2+/+ mice. For each
panel, regions delineated in the low magnification image of the whole TA/EDL
(A,B) are shown as higher magnification views (A1–B2) identified with
corresponding colored frames. Muscles from both mouse strains harbored
typical histology with larger and smaller diameter myofibers with peripheral
nuclei.
regeneratedmyoﬁbers are of MyoD lineage origin (Figure 5). The
GFP reporter has also permitted the observation of (i) infrequent
groups of small-diameter myoﬁbers (Figure 5A), and (ii) the
tiny intrafusal myoﬁbers (Figure 5B) constituting the muscle
spindle apparatus that plays a role in proprioception (Walro
and Kucera, 1999; Kirkpatrick et al., 2008). Interestingly, the
muscle spindle seen in Figure 5B is located within a regenerating
region characterized by central myonuclei and thus most likely
underwent a regeneration process similar to the surrounding
myoﬁbers.
SCs in Isolated Myofibers from
mR1//R2/ Mice Exhibit Impaired
Proliferative Response to FGF2
Based on the outcome of the injury study described above,
FGFR1/FGFR2 do not appear to be essential (at least at the
histological level) for muscle regeneration following cardiotoxin
injury, but it does not necessarily preclude a role for FGF
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FIGURE 4 | Muscle tissue of adult mR1//R2/ mice retains
regenerative activity. Representative images of H&E stained cross
sections of TA/EDL from 4-month-old mR1//R2/ mice, showing
extensive damage at 7 days post cardiotoxin-induced injury, and
progressive recovery at 14 and 21 days post-injury. For each panel,
regions delineated in the low magnification image of the whole
TA/EDL are shown as higher magnification views (A1–C2) identified
with corresponding colored frames; dotted lines in the low
magnification images delineate the outer limits of the region that
has been effectively injured. Morphology of control contralateral TAs
(NaCl-injected, not shown) appeared similar to that of the uninjured
muscle depicted in Figure 3. (A) As seen on day 7 post-injury,
cardiotoxin injection caused massive myofiber degeneration, resulting
in large necrotic regions in which empty remnants of the original
myofibers (A1) and infiltration of inflammatory cells (A2) are
detected; regions with small regenerating myofibers with central
myonuclei (hallmark of regenerating myofibers) were occasionally
observed (A2). (B) On day 14 post-injury, regenerating myofibers
were more abundant (B2), but regions showing infiltration of
inflammatory cells were still occasionally present (B1); asterisk in (B)
and (B2) indicates the scar left at the needle injection point.
(C) By day 21 post-injury, most of the original injured region
showed successful regeneration based on the presence of larger
(relative to day 14) myofibers containing central nuclei and overall
tissue morphology (C2); infiltration of inflammatory cells was only
minimally detected at this stage (C1).
signaling system in muscle regeneration. Indeed, multiple growth
factors have been implicated in muscle regeneration and might
compensate functionally for each other role in the cardiotoxin-
induced muscle regeneration model (Charge and Rudnicki,
2004; Shefer and Yablonka-Reuveni, 2008). Hence, to directly
investigate the impact of Fgfr ablation on SC number and
performance, we analyzed isolated myoﬁbers maintained in
culture conditions where SCs are retained at their native
position by the myoﬁber as the cells undergo proliferation and
diﬀerentiation (Yablonka-Reuveni and Rivera, 1994; Zammit
et al., 2004; Keire et al., 2013). In the current studymyoﬁbers were
isolated from EDL muscles and were either allowed to adhere to
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FIGURE 5 | Fluorescent images of cross sections prepared from
TA isolated 21 days post-injury from a 4-month-old
mR1//R2/ mouse (also harboring the R26mTmG allele)
depicting GFP and Tomato fluorescence, indicative of myogenic
and non-myogenic structures, respectively, with DAPI+ nuclei.
(A–A”) The use of the R26mTmG allele together with the MyoDCre
driver (used for recombining the floxed Fgfr1 and Fgfr2 alleles)
demonstrates that as expected, the regenerated myofibers identified
by their central nuclei, were GFP+, hence, of MyoD lineage origin.
The capillaries and connective tissue surrounding myofibers are
Tomato+ (i.e., of non-MyoD+ origin). (B–B”) In addition to the
standard myofibers (extrafusal), a muscle spindle (arrowhead, higher
magnification view in top left insert) can be observed within a
regenerating region. While the spindle capsule and the material
surrounding each intrafusal myofiber are of a non-MyoD+ origin
(Tomato+ ), similar to the standard myofibers, the intrafusal myofibers
are of MyoD-lineage origin (GFP+ ). Note the distinctive smaller
diameter size of the intrafusal myofibers compared to the larger
extrafusal myofibers. Asterisk indicates the scar (Tomato+ ) left at the
needle injection point. Notably, as shown in panels (A) and (B),
sites with groups of smaller diameter extrafusal myofibers were
observed in addition to the larger diameter myofibers. Morphology of
control contralateral TAs (NaCl-injected, not shown) exhibited no
differences when compared to uninjured muscle depicted in Figure 3.
Matrigel to determine SC numbers on freshly isolated myoﬁbers
according to Pax7 immunostaining (Figure 6A), or maintained
in suspension to investigate SCdynamics (Pax7/MyoD/myogenin
immunostaining) in response to FGF2 over 3 days in culture
(Figure 6B).
The boxplot analysis of freshly isolated EDL myoﬁbers
immunostained for Pax7 (Figure 6A) suggests that within
the four diﬀerent groups identiﬁed as “FGFR-related,”
the mR1//R2/ mice potentially harbor less SCs per
myoﬁber. An ANOVA test indeed revealed a statistically
signiﬁcant diﬀerence. Nevertheless, SC number in myoﬁbers
of mR1//R2/mice does not appear to be overtly aﬀected
when each of the FGFR-related groups are compared with
mice lacking MyoD or α7integrin that show a clear increase or
decrease, respectively, in their SC numbers (Figure 6A). Overall,
the number of SCs per myoﬁber in each of the FGFR-related
groups (and in the MyoD+/− and α7integrin+/− groups) all fall
within the wildtype range of adult male mice (Shefer et al., 2006;
Day et al., 2007, 2010). Notably, the increase in SC numbers
in MyoD-null mice was previously recognized (Megeney et al.,
1996; Yablonka-Reuveni et al., 1999a; Cornelison et al., 2000;
Gayraud-Morel et al., 2007), but while α7integrin has been
known to be expressed in the myogenic lineage, including in SCs
(Burkin and Kaufman, 1999; Sacco et al., 2008; Rooney et al.,
2009; Ieronimakis et al., 2010), we report here the novel ﬁnding
of signiﬁcantly reduced SC numbers in the absence of α7integrin.
To analyze the eﬀect of FGF2 on SC performance, myoﬁbers
were maintained for 3 days in suspension in basal medium
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FIGURE 6 | Satellite cells (SCs) in isolated EDL myofibers from
mR1//R2/ mice do not display a drastic change in their number
but exhibit impaired proliferative response to FGF2. (A) Quantification of
SCs in freshly isolated myofibers from different mouse strains as listed under
the X-axis. SCs were quantified on individual myofibers by Pax7
immunostaining combined with DAPI-staining to highlight both SCs and
myonuclei. Data are summarized as boxplots, depicting the quartile
distribution and mean ± SEM (red marks) for the number of SCs per myofiber;
the whiskers on each side of the box are taken to the minimum and maximum
values. MyoD-null and α7integrin-null data are included for comparison, as
these mutations do drastically affect SC numbers. For each strain as listed
from left to right under the X-axis, the number of myofibers analyzed was 48,
18, 54, 18, 120, 96, 88, and 95, respectively. (B) Single myofibers were
maintained in suspension for 3 days with or without FGF2 supplement
(5 ng/ml), then fixed and analyzed by immunostaining for the expression of the
myogenic markers Pax7, MyoD and myogenin as a means to investigate SC
dynamics. For typical Pax7/MyoD/myogenin immunostaining images see our
previous mouse myofiber studies (Yablonka-Reuveni et al., 1999a; Shefer
et al., 2006; Keire et al., 2013); examples of MyoD staining that depict the
proliferative response of SCs to FGF2 supplementation are shown in
Figure 7. To quantify the effect of FGF2 on SCs, the ratio in average cell
numbers between FGF2-treated and untreated myofibers was determined for
each marker (indicated under X-axis legend). Asterisks denote statistically
significant differences in the number of labeled cells per myofiber between
FGF2-treated and untreated myofibers (single asterisk p < 0.05; triple
asterisks p < 0.001). For each condition as listed from left to right under the
X-axis, the number of myofibers analyzed was 19, 21, 18, 21, 16, 17, 17, 12,
16, 12, 15, and 13, respectively.
(DMEM containing 10% horse serum, which is known to
contain fewer growth promoting factors than fetal bovine
serum) with or without FGF2 supplement. The cultured
myoﬁbers were then analyzed by immunostaining using
antibodies against Pax7, MyoD and myogenin to quantify
SCs and their progeny according to their transcription
factor expression status (Figure 6B) The FGF2-mediated
increase in Pax7+ or MyoD+ cells seen by day 3 in control
(R1+/+R2+/+) cultures is drastically aﬀected in myoﬁbers from
mR1//R2/ mice (exempliﬁed by MyoD immunostaining
in Figures 7A–B”). Indeed, the ratio in average cell numbers
between FGF2-treated and untreated myoﬁbers declined by
∼50% in the mR1//R2/ mice (1.9 [Pax7] and 1.5 [MyoD])
compared to R1+/+/R2+/+ mice (3.8 [Pax7] and 2.8 [MyoD]
Figure 6B). There was a slight decline in Pax7+, MyoD+, and
myogenin+ cell numbers in untreated (i.e., not exposed to
FGF2) mR1//R2/ myoﬁbers. This may be due to the
subtle decline in the initial number of SCs noted in freshly
isolated myoﬁbers (Figure 6A) and/or due to an impaired
response of mR1//R2/ myoﬁbers to the basal levels of
FGF2, available in the cell culture serum or contributed by the
myoﬁbers (Yablonka-Reuveni and Rivera, 1994; Chakkalakal
et al., 2012). The transition to the diﬀerentiated, myogenin+
state, was suppressed by FGF2 in the R1+/+/R2+/+ myoﬁbers
(i.e., the ratio of myogenin+ cells in FGF2-treated vs. untreated
myoﬁbers was 0.1), which is in agreement with the established
FGF2 eﬀect on delaying myogenic diﬀerentiation (Clegg et al.,
1987). Diﬀerently, in the mR1//R2/ mice, albeit the
number of myogenin+ labeled cells appeared slightly reduced
in FGF2-treated vs. untreated myoﬁbers, there was no statistical
diﬀerence between the two groups.
FGFR4 Does Not Appear to Substitute for
the Mitogenic Effect of FGFR1 on SC
Performance in Isolated Myofibers
Overall, the data in Figure 6B demonstrate an impairment of
FGF2-mediated proliferative activity of SCs in isolated myoﬁber
cultures from mice lacking functional FGFR1 (and FGFR2).
This impairment suggests that other FGFRs that are possibly
expressed by SCs cannot substitute for FGFR1 function. As the
expression of Fgfr4 transcripts was indeed detected in freshly
isolated SCs and their progeny (Figures 1 and 2), we set out to
determine if FGFR4 protein is expressed by SCs. Previously we
and others have shown FGFR4 protein in mouse SC progeny
using Western blotting of cultured cells (Kwiatkowski et al.,
2008; Cassano et al., 2011). Here, we show immunodetection
of FGFR4 in limb muscle cross sections (Figures 8A–B”). The
observed FGFR4+ structures are presumptive SCs based on their
location underneath the myoﬁber basal lamina that is highlighted
by laminin immunostaining (Figures 8A–B”). We additionally
show here the expression of FGFR4 protein in mouse myogenic
primary cultures (Figures 8C,C’). FGFR4 was down regulated
in response to FGF2 supplement, therefore it appears to be
functional (Figures 8D,D’).
The inability of the endogenously expressed FGFR4 to rescue
the proliferative eﬀect of FGF2 in isolated myoﬁbers from
mR1//R2/ provides further support to our hypothesis that
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FIGURE 7 | Examples of EDL myofibers isolated from (A–A”)
mR1//R2/ or (B–B”) R1+/+/R2+/+ mice and cultured in
suspension for 3 days with FGF2 supplement and then
immunostained for MyoD, which is expressed by proliferating and
differentiating SCs. DAPI counterstaining detected both the MyoD+ cells
and the myofiber nuclei, but only nuclei at the focal level of the MyoD+ cells
can be seen in the images shown. The apparent difference in diameter
between the two examples of myofibers shown in (A) vs. (B) is arbitrary and
does not reflect a strain difference, as clearly demonstrated by the cross
section images shown in Figure 3.
FGFR4 has a diﬀerent role from that of FGFR1 during adult
myogenesis. Indeed, overexpression studies have indicated that
diﬀerent from the other three FGFRs, FGFR4 appears to be a
poor inducer of mitogenesis, whereas a clear mitogenic eﬀect
was detected when the intracellular domain of overexpressed
FGFR4 was replaced with that of FGFR1 (Ornitz et al., 1996;
Zhang et al., 2006). The poor mitogenic eﬀect of FGFR4 could
be linked to its much reduced tyrosine kinase phosphorylation
compared to the other FGFRs (Kwiatkowski et al., 2008). Our
FGFR4 overexpression studies [(Kwiatkowski et al., 2008); R
Almuly and Z Yablonka-Reuveni, unpublished] have suggested
a role for FGFR4 in suppressing FGFR1 tyrosine kinase activity
and downstream signaling via FRS2-Erk1/2 axis (Goetz and
Mohammadi, 2013), thereby leading cells to withdraw from the
cell cycle. Moreover, an earlier FGFR4 overexpression study
using L6E9 rat myoblasts demonstrated a weak mitogenic
activity for FGFR4 and a role in inhibition of myogenic
diﬀerentiation (Shaoul et al., 1995). Hence, FGFR4 might
provide ﬁne-tuning among proliferation, diﬀerentiation and
renewal, counteracting the role of FGFR1 in enhancing myoblast
proliferation.
Conclusion
This current study of Fgfr expression proﬁle in freshly isolated
SCs and their progeny from adult limb and diaphragm
muscles provides new experimental evidence to the commonly
held convention that of the four FGFRs, only Fgfr1 and
Fgfr4 are of potential relevance to myogenesis. Our earlier
work has suggested that these two FGFRs might have
diﬀerent functional roles during adult myogenesis. To begin
addressing the possible distinct roles of FGFR1 vs. FGFR4,
we employed in the present study a genetic approach relying
on the MyoDCre allele for myogenic-speciﬁc ablation of
FGFR1 (and FGFR2). Albeit this MyoDCre-driven ablation
occurs early during embryogenesis, muscle development
does not seem to be overtly impaired in the absence of
functional FGFR1 (and FGFR2) based on the intact muscle
histology of the adult mR1//R2/ mice. Furthermore,
cardiotoxin-injured muscle of these mR1//R2/ mice
showed eﬀective regeneration. However, the SC mitogenic
response to FGF2 was drastically repressed in isolated
myoﬁber cultures prepared from the myogenic-speciﬁc
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FIGURE 8 | Immuno-detection of FGFR4 protein in muscle tissue
and primary myogenic culture from wildtype mice. (A,B”) Detection
of FGFR4 in hindlimb muscle sections; positive cells are presumptive SCs
based on their location underneath the myofiber basal lamina highlighted
by laminin immunostaining Notably, SC identification using Pax7
immunostaining is precluded as it would require antigen retrieval step
which is not compatible with the conditions used here for FGFR4
detection on unfixed cryosections. As expected, SCs (FGFR4+ ) were more
abundant in (A–A”) the younger aged mouse (12 days old, gastrocnemius
muscle) than in (B–B”) the 30-day-old mouse (TA muscle). Corres-
ponding arrowheads denote common locations in the lower and higher
magnification images. (C–D’) Detection of FGFR4 in primary myogenic
cultures from adult mice; the myogenic nature of the cultured cells was
verified with double immunostaining for desmin as in (Yablonka-Reuveni
et al., 1999a; data not shown). (C,C’) FGFR4 protein expression is unique
to the myogenic cells while residual non-myogenic cells present in this
standard primary culture are negative. (D,D’) FGF2 treatment (20 ng/ml in
DMEM containing 2% horse serum for 16 hours) of mouse primary
myogenic cultures results in the downregulation of FGFR4. Following the
overnight treatment with FGF2, FGFR4-immunosignal is restricted to a
perinuclear compartment likely reflecting receptor desensitization through
its internalization and targeting to endosomes.
Fgfr1/Fgfr2-ablated mice. Collectively, our study indicates that
FGFR1 is important for FGF2-mediated proliferation of SCs,
while the role of the expressed FGFR4 has yet to be resolved. To
further address the role of FGFR1 and FGFR4, we are developing
genetic models for myogenic-speciﬁc ablation of these receptors
in growing and aging mice.
Acknowledgments
We are grateful to Donna Prunkard and Dr. Peter Rabinovitch for
their valuable assistance with cell sorting, performed at the core
facility of the University of Washington Nathan Shock Center
of Excellence. We are also thankful to Dr. David Ornitz for
providing the ﬂoxed Fgfr1/Fgfr2 mice, Dr. David Goldhamer
for the MyoDCre mouse and Dr. Lindsey Muir for her valuable
comments on the manuscript. This work was supported by
grants to ZY-R from the National Institute on Aging (AG013798
and AG021566). ZY-R acknowledges additional support from
the National Institute of Health during the course of this
study (AG035377 and NS090051). MD and MP were supported
by the Genetic Approaches to Aging Training Program (T32
AG000057).
References
Abe, G., Ide, H., and Tamura, K. (2007). Function of FGF signaling in the
developmental process of the median ﬁn fold in zebraﬁsh. Dev. Biol. 304,
355–366. doi: 10.1016/j.ydbio.2006.12.040
Allen, R. E., and Boxhorn, L. K. (1989). Regulation of skeletal muscle
satellite cell proliferation and diﬀerentiation by transforming
growth factor-beta, insulin-like growth factor I, and ﬁbroblast
growth factor. J. Cell. Physiol. 138, 311–315. doi: 10.1002/jcp.10413
80213
Allen, R. E., Dodson, M. V., and Luiten, L. S. (1984). Regulation of skeletal muscle
satellite cell proliferation by bovine pituitary ﬁbroblast growth factor. Exp. Cell
Res. 152, 154–160. doi: 10.1016/0014-4827(84)90239-8
Alterio, J., Courtois, Y., Robelin, J., Bechet, D., and Martelly, I. (1990). Acidic and
basic ﬁbroblast growth factor mRNAs are expressed by skeletal muscle satellite
cells. Biochem. Biophys. Res. Commun. 166, 1205–1212. doi: 10.1016/0006-
291X(90)90994-X
Anderson, J. E. (2006). The satellite cell as a companion in skeletal muscle
plasticity: currency, conveyance, clue, connector and colander. J. Exp. Biol. 209,
2276–2292. doi: 10.1242/jeb.02088
Frontiers in Aging Neuroscience | www.frontiersin.org 13 May 2015 | Volume 7 | Article 85
Yablonka-Reuveni et al. Role of FGFR in adult myogenesis
Bentzinger, C. F., Von Maltzahn, J., and Rudnicki, M. A. (2010). Extrinsic
regulation of satellite cell speciﬁcation. Stem Cell Res. Ther. 1:27. doi:
10.1186/scrt27
Bernet, J. D., Doles, J. D., Hall, J. K., Kelly Tanaka, K., Carter, T. A., and Olwin,
B. B. (2014). p38 MAPK signaling underlies a cell-autonomous loss of stem
cell self-renewal in skeletal muscle of aged mice. Nat. Med. 20, 265–271. doi:
10.1038/nm.3465
Bischoﬀ, R. (1986a). Proliferation of muscle satellite cells on intact myoﬁbers in
culture. Dev. Biol. 115, 129–139. doi: 10.1016/0012-1606(86)90234-4
Bischoﬀ, R. (1986b). A satellite cell mitogen from crushed adult muscle. Dev. Biol.
115, 140–147. doi: 10.1016/0012-1606(86)90235-6
Bischoﬀ, R. (1990). Control of satellite cell proliferation. Adv. Exp. Med. Biol. 280,
147–157; discussion 157–148. doi: 10.1007/978-1-4684-5865-7_17
Brack, A. S., Bildsoe, H., and Hughes, S. M. (2005). Evidence that satellite cell
decrement contributes to preferential decline in nuclear number from large
ﬁbres during murine age-related muscle atrophy. J. Cell Sci. 118, 4813–4821.
doi: 10.1242/jcs.02602
Brack, A. S., and Rando, T. A. (2007). Intrinsic changes and extrinsic inﬂuences
of myogenic stem cell function during aging. Stem Cell Rev. 3, 226–237. doi:
10.1007/s12015-007-9000-2
Burkin, D. J., and Kaufman, S. J. (1999). The alpha7beta1 integrin in
muscle development and disease. Cell Tissue Res. 296, 183–190. doi:
10.1007/s004410051279
Cabrita, M. A., and Christofori, G. (2008). Sprouty proteins, masterminds of
receptor tyrosine kinase signaling. Angiogenesis 11, 53–62. doi: 10.1007/s10456-
008-9089-1
Cassano, M., Dellavalle, A., Tedesco, F. S., Quattrocelli, M., Crippa, S., Ronzoni, F.,
et al. (2011). Alpha sarcoglycan is required for FGF-dependent myogenic
progenitor cell proliferation in vitro and in vivo. Development 138, 4523–4533.
doi: 10.1242/dev.070706
Chakkalakal, J. V., Jones, K. M., Basson, M. A., and Brack, A. S. (2012). The
aged niche disrupts muscle stem cell quiescence. Nature 490, 355–360. doi:
10.1038/nature11438
Charge, S. B., and Rudnicki, M. A. (2004). Cellular and molecular
regulation of muscle regeneration. Physiol. Rev. 84, 209–238. doi:
10.1152/physrev.00019.2003
Clarke, M. S., Khakee, R., and Mcneil, P. L. (1993). Loss of cytoplasmic basic
ﬁbroblast growth factor from physiologically woundedmyoﬁbers of normal and
dystrophic muscle. J. Cell Sci. 106, 121–133.
Clegg, C. H., Linkhart, T. A., Olwin, B. B., and Hauschka, S. D. (1987). Growth
factor control of skeletal muscle diﬀerentiation: commitment to terminal
diﬀerentiation occurs in G1 phase and is repressed by ﬁbroblast growth factor.
J. Cell Biol. 105, 949–956. doi: 10.1083/jcb.105.2.949
Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A.,
et al. (2005). Stem cell function, self-renewal, and behavioral heterogeneity
of cells from the adult muscle satellite cell niche. Cell 122, 289–301. doi:
10.1016/j.cell.2005.05.010
Cornelison, D. D., Filla, M. S., Stanley, H. M., Rapraeger, A. C., and Olwin, B. B.
(2001). Syndecan-3 and syndecan-4 speciﬁcally mark skeletal muscle satellite
cells and are implicated in satellite cell maintenance and muscle regeneration.
Dev. Biol. 239, 79–94. doi: 10.1006/dbio.2001.0416
Cornelison, D. D., Olwin, B. B., Rudnicki, M. A., andWold, B. J. (2000). MyoD(-/-)
satellite cells in single-ﬁber culture are diﬀerentiation defective and MRF4
deﬁcient. Dev. Biol. 224, 122–137. doi: 10.1006/dbio.2000.9682
Cornelison, D. D., and Wold, B. J. (1997). Single-cell analysis of regulatory gene
expression in quiescent and activated mouse skeletal muscle satellite cells. Dev.
Biol. 191, 270–283. doi: 10.1006/dbio.1997.8721
Danoviz, M. E., and Yablonka-Reuveni, Z. (2012). Skeletal muscle satellite cells:
background and methods for isolation and analysis in a primary culture system.
Methods Mol. Biol. 798, 21–52. doi: 10.1007/978-1-61779-343-1_2
Day, K., Paterson, B., and Yablonka-Reuveni, Z. (2009). A distinct proﬁle of
myogenic regulatory factor detection within Pax7+ cells at S phase supports
a unique role of Myf5 during posthatch chicken myogenesis. Dev. Dyn. 238,
1001–1009. doi: 10.1002/dvdy.21903
Day, K., Shefer, G., Richardson, J. B., Enikolopov, G., and Yablonka-Reuveni, Z.
(2007). Nestin-GFP reporter expression deﬁnes the quiescent state of skeletal
muscle satellite cells. Dev. Biol. 304, 246–259. doi: 10.1016/j.ydbio.2006.
12.026
Day, K., Shefer, G., Shearer, A., and Yablonka-Reuveni, Z. (2010). The depletion
of skeletal muscle satellite cells with age is concomitant with reduced capacity
of single progenitors to produce reserve progeny. Dev. Biol. 340, 330–343. doi:
10.1016/j.ydbio.2010.01.006
Delaune, E., Lemaire, P., and Kodjabachian, L. (2005). Neural induction in
Xenopus requires early FGF signalling in addition to BMP inhibition.
Development 132, 299–310. doi: 10.1242/dev.01582
Deng, C. X., Wynshaw-Boris, A., Shen, M. M., Daugherty, C., Ornitz, D. M., and
Leder, P. (1994). Murine FGFR-1 is required for early postimplantation growth
and axial organization. Genes Dev. 8, 3045–3057. doi: 10.1101/gad.8.24.3045
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. (1996). Fibroblast
growth factor receptor 3 is a negative regulator of bone growth. Cell 84,
911–921. doi: 10.1016/S0092-8674(00)81069-7
Dusterhoft, S., Putman, C. T., and Pette, D. (1999). Changes in FGF and
FGF receptor expression in low-frequency-stimulated rat muscles and
rat satellite cell cultures. Diﬀerentiation 65, 203–208. doi: 10.1046/j.1432-
0436.1999.6540203.x
Dvorak, P., Dvorakova, D., Koskova, S., Vodinska, M., Najvirtova, M., Krekac, D.,
et al. (2005). Expression and potential role of ﬁbroblast growth factor 2 and
its receptors in human embryonic stem cells. Stem Cells 23, 1200–1211. doi:
10.1634/stemcells.2004-0303
Eswarakumar, V. P., Lax, I., and Schlessinger, J. (2005). Cellular signaling by
ﬁbroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139–149.
doi: 10.1016/j.cytogfr.2005.01.001
Flintoﬀ-Dye, N. L., Welser, J., Rooney, J., Scowen, P., Tamowski, S., Hatton, W.,
et al. (2005). Role for the alpha7beta1 integrin in vascular development and
integrity. Dev. Dyn. 234, 11–21. doi: 10.1002/dvdy.20462
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., et al.
(2010). Research resource: comprehensive expression atlas of the ﬁbroblast
growth factor system in adult mouse. Mol. Endocrinol. 24, 2050–2064. doi:
10.1210/me.2010-0142
Franzdottir, S. R., Axelsson, I. T., Arason, A. J., Baldursson, O., Gudjonsson, T.,
and Magnusson, M. K. (2010). Airway branching morphogenesis in three
dimensional culture. Respir. Res. 11:162. doi: 10.1186/1465-9921-11-162
Fukui, L., and Henry, J. J. (2011). FGF signaling is required for lens regeneration in
Xenopus laevis. Biol. Bull. 221, 137–145.
Gayraud-Morel, B., Chretien, F., Flamant, P., Gomes, D., Zammit, P. S.,
and Tajbakhsh, S. (2007). A role for the myogenic determination gene
Myf5 in adult regenerative myogenesis. Dev. Biol. 312, 13–28. doi:
10.1016/j.ydbio.2007.08.059
Goetz, R., and Mohammadi, M. (2013). Exploring mechanisms of FGF signalling
through the lens of structural biology.Nat. Rev. Mol. Cell Biol. 14, 166–180. doi:
10.1038/nrm3528
Grounds, M. D., and Yablonka-Reuveni, Z. (1993). Molecular and cell biology of
skeletal muscle regeneration. Mol. Cell Biol. Hum. Dis. Ser. 3, 210–256. doi:
10.1007/978-94-011-1528-5_9
Halevy, O., Piestun, Y., Allouh, M. Z., Rosser, B. W., Rinkevich, Y., Reshef, R., et al.
(2004). Pattern of Pax7 expression during myogenesis in the posthatch chicken
establishes a model for satellite cell diﬀerentiation and renewal. Dev. Dyn. 231,
489–502. doi: 10.1002/dvdy.20151
Harris, J. B. (2003). Myotoxic phospholipases A2 and the regeneration of skeletal
muscles. Toxicon 42, 933–945. doi: 10.1016/j.toxicon.2003.11.011
Hawke, T. J., and Garry, D. J. (2001). Myogenic satellite cells: physiology to
molecular biology. J. Appl. Physiol. 91, 534–551.
Ieronimakis, N., Balasundaram, G., Rainey, S., Srirangam, K., Yablonka-
Reuveni, Z., and Reyes, M. (2010). Absence of CD34 on murine skeletal muscle
satellite cells marks a reversible state of activation during acute injury. PLoS
ONE 5:e10920. doi: 10.1371/journal.pone.0010920
Itoh, N., and Ornitz, D. M. (2011). Fibroblast growth factors: from molecular
evolution to roles in development, metabolism and disease. J. Biochem. (Tokyo)
149, 121–130. doi: 10.1093/jb/mvq121
Joe, A. W., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., et al. (2010). Muscle
injury activates resident ﬁbro/adipogenic progenitors that facilitate myogenesis.
Nat. Cell Biol. 12, 153–163. doi: 10.1038/ncb2015
Jump, S. S., Childs, T. E., Zwetsloot, K. A., Booth, F. W., and Lees,
S. J. (2009). Fibroblast growth factor 2-stimulated proliferation is lower
in muscle precursor cells from old rats. Exp. Physiol. 94, 739–748. doi:
10.1113/expphysiol.2008.046136
Frontiers in Aging Neuroscience | www.frontiersin.org 14 May 2015 | Volume 7 | Article 85
Yablonka-Reuveni et al. Role of FGFR in adult myogenesis
Kanisicak, O., Mendez, J. J., Yamamoto, S., Yamamoto, M., and Goldhamer,
D. J. (2009). Progenitors of skeletal muscle satellite cells express the
muscle determination gene, MyoD. Dev. Biol. 332, 131–141. doi:
10.1016/j.ydbio.2009.05.554
Kastner, S., Elias, M. C., Rivera, A. J., and Yablonka-Reuveni, Z. (2000). Gene
expression patterns of the ﬁbroblast growth factors and their receptors during
myogenesis of rat satellite cells. J. Histochem. Cytochem. 48, 1079–1096. doi:
10.1177/002215540004800805
Keire, P., Shearer, A., Shefer, G., and Yablonka-Reuveni, Z. (2013). Isolation and
culture of skeletalmuscle myoﬁbers as ameans to analyze satellite cells.Methods
Mol. Biol. 946, 431–468. doi: 10.1007/978-1-62703-128-8_28
Kirillova, I., Gussoni, E., Goldhamer, D. J., and Yablonka-Reuveni, Z. (2007).
Myogenic reprogramming of retina-derived cells following their spontaneous
fusion with myotubes. Dev. Biol. 311, 449–463. doi: 10.1016/j.ydbio.2007.
08.056
Kirkpatrick, L. J., Allouh, M. Z., Nightingale, C. N., Devon, H. G., Yablonka-
Reuveni, Z., and Rosser, B. W. (2008). Pax7 shows higher satellite cell
frequencies and concentrations within intrafusal ﬁbers of muscle spindles.
J. Histochem. Cytochem. 56, 831–840. doi: 10.1369/jhc.2008.951608
Kuang, S., Kuroda, K., Le Grand, F., and Rudnicki, M. A. (2007). Asymmetric self-
renewal and commitment of satellite stem cells in muscle. Cell 129, 999–1010.
doi: 10.1016/j.cell.2007.03.044
Kwiatkowski, B. A., Kirillova, I., Richard, R. E., Israeli, D., and Yablonka-
Reuveni, Z. (2008). FGFR4 and its novel splice form inmyogenic cells: interplay
of glycosylation and tyrosine phosphorylation. J. Cell. Physiol. 215, 803–817.
doi: 10.1002/jcp.21365
Lanner, F., and Rossant, J. (2010). The role of FGF/Erk signaling in pluripotent
cells. Development 137, 3351–3360. doi: 10.1242/dev.050146
Le Moigne, A., Martelly, I., Barlovatz-Meimon, G., Franquinet, R., Aamiri, A.,
Frisdal, E., et al. (1990). Characterization of myogenesis from adult satellite cells
cultured in vitro. Int. J. Dev. Biol. 34, 171–180.
Li, J., Han, S., Cousin, W., and Conboy, I. M. (2014). Age-speciﬁc functional
epigenetic changes in p21 and p16 in injury-activated satellite cells. Stem Cells
33, 951–961. doi: 10.1002/stem.1908
Li, Y., He, X., Olauson, H., Larsson, T. E., and Lindgren, U. (2013). FGF23 aﬀects
the lineage fate determination of mesenchymal stem cells. Calcif. Tissue Int. 93,
556–564. doi: 10.1007/s00223-013-9795-6
Mason, I. (2007). Initiation to end point: the multiple roles of ﬁbroblast
growth factors in neural development. Nat. Rev. Neurosci. 8, 583–596. doi:
10.1038/nrn2189
Mauro, A. (1961). Satellite cell of skeletal muscle ﬁbers. J. Biophys. Biochem. Cytol.
9, 493–495. doi: 10.1083/jcb.9.2.493
Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., and Rudnicki, M. A. (1996).
MyoD is required for myogenic stem cell function in adult skeletal muscle.
Genes Dev. 10, 1173–1183. doi: 10.1101/gad.10.10.1173
Mohammadi, M., Mcmahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K.,
et al. (1997). Structures of the tyrosine kinase domain of ﬁbroblast growth
factor receptor in complex with inhibitors. Science 276, 955–960. doi:
10.1126/science.276.5314.955
Montarras, D., L’honore, A., and Buckingham, M. (2013). Lying low but ready
for action: the quiescent muscle satellite cell. FASEB J. 280, 4036–4050. doi:
10.1111/febs.12372
Moss, F. P., and Leblond, C. P. (1971). Satellite cells as the source of nuclei
in muscles of growing rats. Anat. Rec. 170, 421–435. doi: 10.1002/ar.10917
00405
Motohashi, N., Asakura, Y., and Asakura, A. (2014). Isolation, culture,
and transplantation of muscle satellite cells. J. Vis. Exp. 73:e50074. doi:
10.3791/50074 (2013)
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., and Luo, L. (2007).
A global double-ﬂuorescent Cre reporter mouse. Genesis 45, 593–605. doi:
10.1002/dvg.20335
Ohta, H., and Itoh, N. (2014). Roles of FGFs as adipokines in adipose tissue
development, remodeling, and metabolism. Front. Endocrinol. (Lausanne) 5:18.
doi: 10.3389/fendo.2014.00018
Oliver, L., Raulais, D., and Vigny, M. (1992). Acidic ﬁbroblast growth factor (aFGF)
in developing normal and dystrophic (mdx) mouse muscles. Distribution in
degenerating and regenerating mdx myoﬁbres. Growth Factors 7, 97–106. doi:
10.3109/08977199209046399
Olwin, B. B., Arthur, K., Hannon, K., Hein, P., Mcfall, A., Riley, B.,
et al. (1994). Role of FGFs in skeletal muscle and limb development.
Mol. Reprod. Dev. 39, 90–100; discussion 100–101. doi: 10.1002/mrd.10803
90114
Ornitz, D. M. (2000). FGFs, heparan sulfate and FGFRs: complex interactions
essential for development. Bioessays 22, 108–112. doi: 10.1002/(SICI)1521-
1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M
Ornitz, D. M., Xu, J., Colvin, J. S., Mcewen, D. G., Macarthur, C. A., Coulier, F.,
et al. (1996). Receptor speciﬁcity of the ﬁbroblast growth factor family. J. Biol.
Chem. 271, 15292–15297. doi: 10.1074/jbc.271.25.15292
Phelps, M., Pettan-Brewer, C., Ladiges, W., and Yablonka-Reuveni, Z. (2013).
Decline in muscle strength and running endurance in klotho deﬁcient C57BL/6
mice. Biogerontology 14, 729–739. doi: 10.1007/s10522-013-9447-2
Rando, T. A., and Blau, H. M. (1994). Primary mouse myoblast puriﬁcation,
characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol.
125, 1275–1287. doi: 10.1083/jcb.125.6.1275
Rooney, J. E., Gurpur, P. B., Yablonka-Reuveni, Z., and Burkin, D. J.
(2009). Laminin-111 restores regenerative capacity in a mouse model for
alpha7 integrin congenital myopathy. Am. J. Pathol. 174, 256–264. doi:
10.2353/ajpath.2009.080522
Rudnicki, M. A., Braun, T., Hinuma, S., and Jaenisch, R. (1992). Inactivation
of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5
and results in apparently normal muscle development. Cell 71, 383–390. doi:
10.1016/0092-8674(92)90508-A
Sacco, A., Doyonnas, R., Kraft, P., Vitorovic, S., and Blau, H. M. (2008). Self-
renewal and expansion of single transplanted muscle stem cells. Nature 456,
502–506. doi: 10.1038/nature07384
Schultz, E. (1996). Satellite cell proliferative compartments in growing skeletal
muscles. Dev. Biol. 175, 84–94. doi: 10.1006/dbio.1996.0097
Schultz, E., Gibson, M. C., and Champion, T. (1978). Satellite cells are mitotically
quiescent in mature mouse muscle: an EM and radioautographic study. J. Exp.
Zool. 206, 451–456. doi: 10.1002/jez.1402060314
Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and
Rudnicki, M. A. (2000). Pax7 is required for the speciﬁcation of myogenic
satellite cells. Cell 102, 777–786. doi: 10.1016/S0092-8674(00)00066-0
Shaoul, E., Reich-Slotky, R., Berman, B., and Ron, D. (1995). Fibroblast growth
factor receptors display both common and distinct signaling pathways.
Oncogene 10, 1553–1561.
Sheehan, S. M., and Allen, R. E. (1999). Skeletal muscle satellite cell proliferation
in response to members of the ﬁbroblast growth factor family and hepatocyte
growth factor. J. Cell. Physiol. 181, 499–506. doi: 10.1002/(SICI)1097-
4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1
Shefer, G., Rauner, G., Stuelsatz, P., Benayahu, D., and Yablonka-Reuveni, Z.
(2013). Moderate-intensity treadmill running promotes expansion of the
satellite cell pool in young and old mice. FASEB J. 280, 4063–4073. doi:
10.1111/febs.12228
Shefer, G., Rauner, G., Yablonka-Reuveni, Z., and Benayahu, D. (2010). Reduced
satellite cell numbers and myogenic capacity in aging can be alleviated by
endurance exercise. PLoS ONE 5:e13307. doi: 10.1371/journal.pone.0013307
Shefer, G., Van DeMark, D. P., Richardson, J. B., and Yablonka-Reuveni, Z. (2006).
Satellite-cell pool size does matter: deﬁning the myogenic potency of aging
skeletal muscle. Dev. Biol. 294, 50–66. doi: 10.1016/j.ydbio.2006.02.022
Shefer, G., and Yablonka-Reuveni, Z. (2008). “Ins and outs of satellite cell
myogenesis: the role of the ruling growth factors,” in Skeletal Muscle Repair and
Regeneration, eds S. Schiaﬃno and T. Partridge (Dordrecht: Springer), 107–144.
Spandidos, A., Wang, X., Wang, H., and Seed, B. (2010). PrimerBank: a resource
of human and mouse PCR primer pairs for gene expression detection and
quantiﬁcation. Nucleic Acids Res. 38, D792–D799. doi: 10.1093/nar/gkp1005
Stuelsatz, P., Keire, P., Almuly, R., and Yablonka-Reuveni, Z. (2012).
A contemporary atlas of the mouse diaphragm: myogenicity, vascularity,
and the pax3 connection. J. Histochem. Cytochem. 60, 638–657. doi:
10.1369/0022155412452417
Stuelsatz, P., Shearer, A., Li, Y., Muir, L. A., Ieronimakis, N., Shen, Q. W., et al.
(2015). Extraocular muscle satellite cells are high performance myo-engines
retaining eﬃcient regenerative capacity in dystrophin deﬁciency.Dev. Biol. 397,
31–44. doi: 10.1016/j.ydbio.2014.08.035
Stuelsatz, P., Shearer, A., and Yablonka-Reuveni, Z. (2014). Ancestral Myf5 gene
activity in periocular connective tissue identiﬁes a subset of ﬁbro/adipogenic
Frontiers in Aging Neuroscience | www.frontiersin.org 15 May 2015 | Volume 7 | Article 85
Yablonka-Reuveni et al. Role of FGFR in adult myogenesis
progenitors but does not connote a myogenic origin. Dev. Biol. 385, 366–379.
doi: 10.1016/j.ydbio.2013.08.010
Thomsen, M. K., Butler, C. M., Shen, M. M., and Swain, A. (2008).
Sox9 is required for prostate development. Dev. Biol. 316, 302–311. doi:
10.1016/j.ydbio.2008.01.030
Trokovic, R., Trokovic, N., Hernesniemi, S., Pirvola, U., Vogt Weisenhorn, D. M.,
Rossant, J., et al. (2003). FGFR1 is independently required in both developing
mid- and hindbrain for sustained response to isthmic signals. EMBO J. 22,
1811–1823. doi: 10.1093/emboj/cdg169
Udayakumar, T. S., Bair, E. L., Nagle, R. B., and Bowden, G. T. (2003).
Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate
tumor growth, promatrilysin, and PSA expression. Mol. Carcinog. 38, 70–77.
doi: 10.1002/mc.10146
Valdez, M. R., Richardson, J. A., Klein, W. H., and Olson, E. N. (2000). Failure
of Myf5 to support myogenic diﬀerentiation without myogenin, MyoD, and
MRF4. Dev. Biol. 219, 287–298. doi: 10.1006/dbio.2000.9621
Vatsveen, T. K., Brenne, A. T., Dai, H. Y., Waage, A., Sundan, A., and Borset, M.
(2009). FGFR3 is expressed and is important for survival in INA-6, a human
myeloma cell line without a t(4;14). Eur. J. Haematol. 83, 471–476. doi:
10.1111/j.1600-0609.2009.01312.x
Walro, J.M., and Kucera, J. (1999).Why adult mammalian intrafusal and extrafusal
ﬁbers contain diﬀerent myosin heavy-chain isoforms. Trends Neurosci. 22,
180–184. doi: 10.1016/S0166-2236(98)01339-3
Wang, Y. X., Dumont, N. A., and Rudnicki, M. A. (2014). Muscle stem cells at a
glance. J. Cell Sci. 127, 1–6. doi: 10.1242/jcs.151209
Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., et al.
(1991). The myoD gene family: nodal point during speciﬁcation of the muscle
cell lineage. Science 251, 761–766. doi: 10.1126/science.1846704
White, A. C., Lavine, K. J., and Ornitz, D. M. (2007). FGF9 and SHH regulate
mesenchymal Vegfa expression and development of the pulmonary capillary
network. Development 134, 3743–3752. doi: 10.1242/dev.004879
White, R. B., Bierinx, A. S., Gnocchi, V. F., and Zammit, P. S. (2010). Dynamics
of muscle ﬁbre growth during postnatal mouse development. BMC Dev. Biol.
10:21. doi: 10.1186/1471-213X-10-21
Wozniak, A. C., and Anderson, J. E. (2007). Nitric oxide-dependence of satellite
stem cell activation and quiescence on normal skeletal muscle ﬁbers. Dev. Dyn.
236, 240–250. doi: 10.1002/dvdy.21012
Xu, X., Qiao, W., Li, C., and Deng, C. X. (2002). Generation of Fgfr1 conditional
knockout mice. Genesis 32, 85–86. doi: 10.1002/gene.10028
Yablonka-Reuveni, Z. (2011). The skeletal muscle satellite cell: still young
and fascinating at 50. J. Histochem. Cytochem. 59, 1041–1059. doi:
10.1369/0022155411426780
Yablonka-Reuveni, Z., and Day, K. (2011). “Skeletal muscle stem cells in the
spotlight: the satellite cell,” in Regenerating the Heart: Stem Cells and the
Cardiovascular System, eds I. Cohen and G. Gaudette (New York, NY: Springer,
Humana Press), 173–200.
Yablonka-Reuveni, Z., Day, K., Vine, A., and Shefer, G. (2008). Deﬁning the
transcriptional signature of skeletal muscle stem cells. J. Anim. Sci. 86, E207–
E216. doi: 10.2527/jas.2007-0473
Yablonka-Reuveni, Z., and Rivera, A. J. (1994). Temporal expression of regulatory
and structural muscle proteins during myogenesis of satellite cells on isolated
adult rat ﬁbers. Dev. Biol. 164, 588–603. doi: 10.1006/dbio.1994.1226
Yablonka-Reuveni, Z., and Rivera, A. J. (1997a). Inﬂuence of PDGF-BB on
proliferation and transition through the MyoD-myogenin-MEF2A expression
program during myogenesis in mouse C2 myoblasts. Growth Factors 15, 1–27.
doi: 10.3109/08977199709002109
Yablonka-Reuveni, Z., and Rivera, A. J. (1997b). Proliferative dynamics and the role
of FGF2 during myogenesis of rat satellite cells on isolated ﬁbers. Basic Appl.
Myol. 7, 189–202.
Yablonka-Reuveni, Z., Rudnicki, M. A., Rivera, A. J., Primig, M., Anderson, J. E.,
and Natanson, P. (1999a). The transition from proliferation to diﬀerentiation is
delayed in satellite cells from mice lacking MyoD. Dev. Biol. 210, 440–455. doi:
10.1006/dbio.1999.9284
Yablonka-Reuveni, Z., Seger, R., and Rivera, A. J. (1999b). Fibroblast growth
factor promotes recruitment of skeletal muscle satellite cells in young and
old rats. J. Histochem. Cytochem. 47, 23–42. doi: 10.1177/0022155499047
00104
Yamada, S., Buﬃnger, N., Dimario, J., and Strohman, R.C. (1989). Fibroblast
growth factor is stored in ﬁber extracellular matrix and plays a role in
regulating muscle hypertrophy. Med. Sci. Sports Exerc. 21, S173–S180. doi:
10.1249/00005768-198910001-00009
Yamaguchi, T. P., Harpal, K., Henkemeyer, M., and Rossant, J. (1994). fgfr-1
is required for embryonic growth and mesodermal patterning during mouse
gastrulation. Genes Dev. 8, 3032–3044. doi: 10.1101/gad.8.24.3032
Yamamoto, M., Shook, N. A., Kanisicak, O., Yamamoto, S., Wosczyna, M. N.,
Camp, J. R., et al. (2009). A multifunctional reporter mouse line for Cre- and
FLP-dependent lineage analysis. Genesis 47, 107–114. doi: 10.1002/dvg.20474
Yin, H., Price, F., and Rudnicki, M. A. (2013). Satellite cells and the muscle stem
cell niche. Physiol. Rev. 93, 23–67. doi: 10.1152/physrev.00043.2011
Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E. N., et al. (2003). Conditional
inactivation of FGF receptor 2 reveals an essential role for FGF signaling
in the regulation of osteoblast function and bone growth. Development 130,
3063–3074. doi: 10.1242/dev.00491
Zammit, P. S., Golding, J. P., Nagata, Y., Hudon, V., Partridge, T. A.,
and Beauchamp, J. R. (2004). Muscle satellite cells adopt divergent
fates: a mechanism for self-renewal? J. Cell Biol. 166, 347–357. doi:
10.1083/jcb.200312007
Zammit, P. S., Partridge, T. A., and Yablonka-Reuveni, Z. (2006). The skeletal
muscle satellite cell: the stem cell that came in from the cold. J. Histochem.
Cytochem. 54, 1177–1191. doi: 10.1369/jhc.6R6995.2006
Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., and
Ornitz, D. M. (2006). Receptor speciﬁcity of the ﬁbroblast growth factor family.
The complete mammalian FGF family. J. Biol. Chem. 281, 15694–15700. doi:
10.1074/jbc.M601252200
Zhao, P., and Hoﬀman, E. P. (2004). Embryonic myogenesis pathways in muscle
regeneration. Dev. Dyn. 229, 380–392. doi: 10.1002/dvdy.10457
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2015 Yablonka-Reuveni, Danoviz, Phelps and Stuelsatz. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 16 May 2015 | Volume 7 | Article 85
